Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
Clinical trial NCT05482451 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05482451
- Sponsor
- China Medical University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2025-02-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.